EGF Theramed Health Corp. (EVAHF)

USD 0.15

(0.0%)

Market Cap (In USD)

1.71 Million

Revenue (In USD)

-

Net Income (In USD)

-623 Thousand

Avg. Volume

264.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.011-0.3
PE
-
EPS
-
Beta Value
-2.354
ISIN
CA2684692023
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Mr. Connor Yuen
Employee Count
-
Website
https://www.egftheramedhealth.com
Ipo Date
2017-03-01
Details
EGF Theramed Health Corp. provides psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.